NASDAQ: ESLA
Estrella Immunopharma Inc Stock Forecast, Predictions & Price Target

Analyst price target for ESLA

Based on 1 analyst offering 12 month price targets for Estrella Immunopharma Inc

Min Forecast
$16.00+1,500%
Avg Forecast
$16.00+1,500%
Max Forecast
$16.00+1,500%

Should I buy or sell ESLA stock?

Based on 1 analyst offering ratings for Estrella Immunopharma Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ESLA stock forecasts and price targets.

ESLA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-21

1 of 1

ESLA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ESLA$1.00$16.00+1,500.00%Strong Buy
RADX$5.55$15.00+170.27%Strong Buy
RNTX$1.67N/AN/A
CASI$2.37N/AN/A
PVLA$27.27$43.20+58.42%Strong Buy

Estrella Immunopharma Stock Forecast FAQ

Is Estrella Immunopharma Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ESLA) stock is to Strong Buy ESLA stock.

Out of 1 analyst, 1 (100%) are recommending ESLA as a Strong Buy, 0 (0%) are recommending ESLA as a Buy, 0 (0%) are recommending ESLA as a Hold, 0 (0%) are recommending ESLA as a Sell, and 0 (0%) are recommending ESLA as a Strong Sell.

If you're new to stock investing, here's how to buy Estrella Immunopharma stock.

What is ESLA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ESLA price target, the average ESLA price target is $16.00, with the highest ESLA stock price forecast at $16.00 and the lowest ESLA stock price forecast at $16.00.

The Wall Street analyst predicted that Estrella Immunopharma's share price could reach $16.00 by Feb 21, 2026. The average Estrella Immunopharma stock price prediction forecasts a potential upside of 1,500% from the current ESLA share price of $1.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.